Health IT Analytics February 20, 2020
The Institute for Gene Therapies will bring together experts across healthcare and help support treatments for rare and common chronic diseases.
The Institute for Gene Therapies (IGT), a new advocacy foundation focused on policy issues surrounding gene therapies, recently launched with the goal of modernizing US regulatory and reimbursement framework for gene therapies.
According to IGT, the US health system currently spends about 85 cents of every healthcare dollar managing the symptoms of chronic diseases over a patient’s lifetime. With gene therapies, providers could alter patients’ non-functioning genes or replace absent ones, leading to long-lasting effects and potentially reshaping the way thousands of diseases are treated.
While traditional biologic and pharmaceutical medicines help manage the symptoms of disease over time,...
Today's Sponsors
Today's Sponsor